Live Feed
Delayed 3mPress · Insider · SEC · Financials
Signed out · 3-min delay · Sign up for real-time
- New insider Scott Sauer claimed ownership of 8,886 units of Common Shares of Beneficial Interest (SEC Form 3)
3 - PennyMac Mortgage Investment Trust (0001464423) (Issuer)
- Chief Legal Officer & Corp Sec Ashe Gena L exercised 29,368 shares at a strike of $43.99, covered exercise/tax liability with 15,657 shares and sold $1,440,049 worth of shares (17,711 units at $81.31), decreasing direct ownership by 30% to 9,531 units (SEC Form 4) (withholding obligation)
4 - Anterix Inc. (0001304492) (Issuer)
- Director Grissinger Michael was granted 3,135 shares, increasing direct ownership by 109% to 6,024 units (SEC Form 4)
4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
- Director Gruia Gabriela was granted 3,135 shares, increasing direct ownership by 300% to 4,180 units (SEC Form 4)
4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
- Director Peters Richard was granted 3,135 shares, increasing direct ownership by 101% to 6,254 units (SEC Form 4)
4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
- Director Henneman John B Iii was granted 3,135 shares, increasing direct ownership by 31% to 13,364 units (SEC Form 4)
4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
- Director Bizzari Jean-Pierre was granted 3,135 shares, increasing direct ownership by 300% to 4,180 units (SEC Form 4)
4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
- Director Fleischhauer Mark sold $279,403 worth of shares (3,500 units at $79.83), decreasing direct ownership by 22% to 12,769 units (SEC Form 4)
4 - Anterix Inc. (0001304492) (Issuer)
- Director Duey Marc was granted 3,135 shares, increasing direct ownership by 1% to 259,290 units (SEC Form 4)
4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
- Director Pamukcu Rifat was granted 3,135 shares, increasing direct ownership by 58% to 8,581 units (SEC Form 4)
4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
- Director Seizinger Bernd R. was granted 3,135 shares, increasing direct ownership by 7% to 48,910 units (SEC Form 4)
4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
- Director Yazdi Mahvash sold $560,000 worth of shares (7,000 units at $80.00), decreasing direct ownership by 27% to 19,407 units (SEC Form 4)
4 - Anterix Inc. (0001304492) (Issuer)
- Chief Credit Officer Kundich Ronald covered exercise/tax liability with 3,982 shares, decreasing direct ownership by 2% to 234,306 units (SEC Form 4) (withholding obligation)
4 - Trinity Capital Inc. (0001786108) (Issuer)
- CEO, President and CIO Brown Kyle Steven covered exercise/tax liability with 10,743 shares, decreasing direct ownership by 2% to 609,966 units (SEC Form 4) (tax liability)
4 - Trinity Capital Inc. (0001786108) (Issuer)